| 02-Feb-10 08:30AM | DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference PR Newswire |
| 13-Nov-09 09:05AM | DUSA PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 10-Nov-09 09:24AM | New Star Analyst Rankings for DUSA Pharmaceuticals, Inc. StarMine |
| 06:33AM | InPlay: DUSA Pharma announces independent study utilizing cyclic levulan PDT finds 95% reduction in new squamous cell carcinoma lesions in solid organ transplant recipients over a 2 yr period Briefing.com |
| 06-Nov-09 03:36PM | DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online +14.41% |
| 03:26PM | DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009 PR Newswire |
| 07:07AM | Q3 2009 DUSA Pharmaceuticals Earnings Release - 06:30 am ET CCBN |
| 06:30AM | DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results PR Newswire |
| 03-Nov-09 06:30AM | DUSA Pharmaceuticals, Inc.(R) Announces Third Quarter Financial Results and Corporate Highlights Conference Call PR Newswire +13.68% |
| 02-Nov-09 03:09PM | CEO Interview: Provectus Pharmaceuticals, Inc. - Peter R. Culpepper Wall Street Transcript |
| 28-Oct-09 06:30AM | DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units PR Newswire -8.89% |
| 21-Oct-09 06:30AM | DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America PR Newswire +10.77% |
| 28-Sep-09 11:16AM | [video] The Pisani Paradox at TheStreet.com |
| 22-Sep-09 08:30AM | DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference PR Newswire |
| 02-Sep-09 08:30AM | DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference PR Newswire |
| 11-Aug-09 03:08PM | DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q2 2009 DUSA Pharmaceuticals Earnings Release - 06:30 am ET CCBN |
| 06:30AM | DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results PR Newswire |
| 06-Aug-09 06:30AM | DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call PR Newswire |
| 12-May-09 02:51PM | DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q1 2009 DUSA Pharmaceuticals Earnings Release - 06:30 am ET CCBN |
| 06:30AM | DUSA Pharmaceuticals Reports First Quarter 2009 Corporate Highlights and Financial Results Marketwire |
| 11-May-09 06:30AM | DUSA Initiates Clinical Trial of Levulan(R) PDT on High-Risk Solid Organ Transplant Recipients Marketwire +6.72% |
| 06-May-09 04:15PM | DUSA Pharmaceuticals, Inc. Announces First Quarter Financial Results and Corporate Highlights Conference Call Marketwire |
| 05-May-09 06:30AM | DUSA Hits the Road With The Skin Cancer Foundation to Raise Awareness of Skin Cancer Marketwire |
| 27-Apr-09 04:34PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online +17.27% |
| 09-Apr-09 11:05AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online +9.84% |
| 11-Mar-09 05:16PM | DUSA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 07:07AM | Q4 2008 DUSA Pharmaceuticals Earnings Release - 06:30 am ET CCBN |
| 06:30AM | DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Corporate Highlights and Financial Results Marketwire |
| 06-Mar-09 08:30AM | DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2008 Financial Results and Corporate Highlights Conference Call Marketwire |
| 04-Feb-09 05:00PM | DUSA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference Marketwire |
| 29-Jan-09 01:19PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 01:15PM | DUSA Elects Alexander Casdin to Board of Directors Marketwire |
| 07-Jan-09 09:00AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online -8.18% |
| 05-Dec-08 02:49PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 04-Nov-08 08:30AM | DUSA Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Marketwire -5.77% |
| 03-Nov-08 07:07AM | Q3 2008 DUSA Pharmaceuticals Earnings Release - Before Market Open CCBN -5.45% |
| 06:30AM | DUSA Pharmaceuticals Reports Third Quarter 2008 Corporate Highlights and Financial Results Marketwire |
| 27-Oct-08 08:30AM | DUSA Pharmaceuticals, Inc. Announces Third Quarter Financial Results and Corporate Highlights Conference Call Marketwire |
| 23-Oct-08 06:01AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online -28.77% |
| 22-Oct-08 05:17PM | UPDATE - Dusa to stop developing acne treatment; shares fall at Reuters |
| 04:00PM | DUSA Announces Results for Phase IIB Trial Of Levulan(R) Photodynamic Therapy for Moderate to Severe Acne Marketwire |
| 20-Oct-08 04:06PM | Study backs laser treatment for sun-damaged skin at Reuters +7.46% |
| 07-Oct-08 04:44AM | Coverage initiated on DUSA Pharma by Rodman & Renshaw Briefing.com +12.50% |
| 24-Sep-08 08:37AM | Zacks #1 Rank Additions for Wednesday Zacks.com +5.88% |
| 14-Aug-08 10:50AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online |
| 06:30AM | DUSA Announces Patent Licensing Agreement Marketwire |
| 12-Aug-08 08:00AM | DUSA Pharmaceuticals to Present at the Noble Financial Equity Conference Marketwire |
| 08-Aug-08 03:41PM | DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online +16.67% |
| 07:07AM | Q2 2008 DUSA Pharmaceuticals Earnings Release - 06:30 am ET CCBN |
| 06:30AM | DUSA Pharmaceuticals Reports Second Quarter 2008 Corporate Highlights and Financial Results Marketwire |
| 04-Aug-08 01:53PM | DUSA Pharmaceuticals, Inc. Announces Revised Schedule for Second Quarter Financial Results and Corporate Highlights Conference Call Marketwire -7.69% |
| 31-Jul-08 08:00AM | DUSA Pharmaceuticals, Inc. to Host Second Quarter Financial Results and Corporate Highlights Conference Call Marketwire -6.06% |
| 18-Jul-08 11:51AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online -7.61% |
| 09:00AM | DUSA Announces Update on Nicomide(R) Status Marketwire |
| 19-Jun-08 08:00AM | DUSA Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference on June 26 Marketwire |
| 16-May-08 02:36PM | Dusa Pharmaceuticals files shelf registration AP |
| 01:45PM | DUSA Files Form S-3 Shelf Registration Statement Marketwire |
| 01:02PM | Dusa Pharma files $75 mln mixed shelf offering at Reuters |
| 07-May-08 05:20PM | DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q1 2008 DUSA Pharmaceuticals Earnings Release - 06:30 am ET CCBN |
| 06:30AM | DUSA Pharmaceuticals Reports First Quarter 2008 Corporate Highlights and Financial Results Marketwire |
| 02-May-08 08:00AM | DUSA Pharmaceuticals, Inc. to Host First Quarter Financial Results and Corporate Highlights Conference Call Marketwire |
| 01-May-08 06:30AM | Phase I Clinical Trial of Photodynamic Therapy (PDT) Underway for Potential New Treatment of Oral Precancerous Lesions Marketwire |
| 29-Apr-08 06:02AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online |
| 21-Apr-08 04:59PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 04:45PM | DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness Marketwire |
| 31-Mar-08 06:30AM | DUSA Completes Enrollment for Phase IIb Trial of Levulan(R) Photodynamic Therapy for Moderate to Severe Acne Marketwire |
| 11-Mar-08 06:00AM | DUSA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 06-Mar-08 04:29PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online |
| 06:30AM | DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT in Brazil Marketwire |
| 04-Mar-08 02:47PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 06:30AM | DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results Marketwire |
| 28-Feb-08 08:00AM | DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results Conference Call Marketwire |
| 13-Feb-08 08:00AM | DUSA Pharmaceuticals to Present at Roth Capital Partners 20th Annual Growth Stock Conference Marketwire |
| 06-Feb-08 06:00AM | Leading Investigators Highlight Advances in Photodynamic Therapy at the American Academy of Dermatology Annual Meeting Marketwire |
| 31-Jan-08 11:58AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 18-Jan-08 03:50PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online |
| 26-Nov-07 02:36PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online |
| 09-Nov-07 03:48PM | DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:31AM | DUSA Pharmaceuticals' third-quarter loss narrows at MarketWatch |
| 07:07AM | Q3 2007 DUSA Pharmaceuticals Earnings Release - Before Market Open CCBN |
| 06:44AM | Dusa Pharmaceuticals Inc Q3 results at Reuters |
| 06:30AM | DUSA Pharmaceuticals Reports Third Quarter 2007 Financial Results and Corporate Highlights Marketwire |
| 02-Nov-07 03:20PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year EDGAR Online |
| 01-Nov-07 08:00AM | DUSA Pharmaceuticals, Inc. to Host Third Quarter Financial Results and Corporate Highlights Conference Call Marketwire |
| 30-Oct-07 11:09AM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events EDGAR Online |
| 08:00AM | DUSA Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference Marketwire |
| 06:30AM | DUSA Pharmaceuticals Announces $11 Million in Private Placement of Common Stock and Warrants to Institutional Investors Marketwire |
| 29-Oct-07 03:50PM | DUSA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 02:17PM | UPDATE - Dusa, River's Edge settle acne drug patent suit at Reuters |
| 08:00AM | DUSA Pharmaceuticals to Present at the CIBC World Markets 18th Annual Healthcare Conference Marketwire |
| 07:16AM | Dusa, River's Edge Settle Patent Claim AP |
| 06:49AM | Dusa reaches settlement with River's Edge over Nicomide at MarketWatch |
